marion laboratories inc stock rose sharply today after company presented bullish earnings scenario meeting for pharmaceutical analysts monday traders and analysts said company said expects earnings for fiscal 1987 ending june rise more pct over year ago pronouncement encouraged analyst david crossen sanford bernstein and raise his earnings estimates for company dlrs share 1987 compared his previous estimate dlrs share last year company earned cts share marion stock gained meeting pharmaceutical analysts marion president fred lyons said wall street eanrings estimates dlrs share for fiscal 1987 expected even aggressive side this range cts low lyons said strong performance second half this year will from fourth quarter introduction and 120 cardizem tablets analyst crossen said cardizem which treats angina also expected approved for treatment hypertension end year crossen said because marion still just small company growth cardizem having big impact bottom line raised fiscal 1988 earnings estimates dlrs share from his previous estimate dlrs share company has broad new product pipeline industry and far concerned most innovative company business said for five years through 1991 crossen expects marion have growth rate pct reuter 